A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation

類似資料

• Gene-based treatment options for Usher type 1C by translational read-through of a nonsense mutation
  著者:: Wolfrum, U, 等
  出版事項: (2012)
• Nonsense suppression activity of PTC124 (ataluren)
  著者:: Peltz, Stuart W., 等
  出版事項: (2009)
• Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations
  著者:: Nudelman, Igor, 等
  出版事項: (2009)
• Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations
  著者:: Sabbavarapu, Narayana Murthy, 等
  出版事項: (2016)
• Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54
  著者:: Rowe, Steven M., 等
  出版事項: (2011)